GENE ONLINE|News &
Opinion
Blog

2025-10-06|

Frenchwoman Gisèle Pelicot Faces Court as Convicted Assailant Appeals Sentence in Decade-Long Abuse Case

by Mark Chiang
Share To

Gisèle Pelicot, a Frenchwoman whose story has become emblematic of feminist advocacy, is set to return to court as one of the men convicted in her case appeals his sentence. The case centers on allegations that Pelicot’s husband drugged her and facilitated sexual assaults against her by multiple men over nearly a decade. The appeal hearing will bring Pelicot face-to-face with one of the individuals found guilty in connection with these crimes.

Pelicot’s case gained widespread attention due to its harrowing details and broader implications regarding consent and accountability. Her husband was accused of orchestrating the assaults by drugging her without her knowledge and inviting others to participate. Several men were subsequently convicted for their involvement. The upcoming court proceedings will focus on an appeal filed by one of those convicted, challenging aspects of his sentencing or conviction. This legal development marks another chapter in a case that has sparked significant public discourse about systemic failures in addressing sexual violence and abuse.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: October 6, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Study Identifies Roles of CD46 and CD55 in Acute Lymphocytic and Myelogenous Leukemia
2026-01-13
LATEST
Study Identifies Roles of CD46 and CD55 in Acute Lymphocytic and Myelogenous Leukemia
2026-01-13
Jubilant Biosys Opens New Noida Facility to Double Early Chemistry Scale-Up Capacity
2026-01-13
Researchers Develop Precise DNA Rewriting Method for Mammalian Cells Using Programmable Tools
2026-01-13
Study Finds Limnospira indica Enhances Plant Growth and Alters Rhizosphere and Endosphere Microbial Communities
2026-01-13
Pharmaceutical Companies Urge FDA to Revise Post-Approval Change Rules to Facilitate US Manufacturing
2026-01-13
First-of-Its-Kind AI Drug Discovery Lab: NVIDIA, Eli Lilly Announce $1B Investment at J.P. Morgan Healthcare
2026-01-12
Retired DEA Judge John Mulrooney and Attorney Andrew Hull to Present on Controlled Substances at January 2026 ACI Summit
2026-01-12
EVENT
2026-01-12
J.P. Morgan Healthcare Conference
San Francisco, California
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
Scroll to Top